Skip to main content
Log in

Pharmacokinetics of Aminolevulinic Acid After Intravesical Administration to Dogs

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. To examine the stability and systemic absorption of aminolevulinic acid (ALA) in dogs during intravesical administration.

Methods. Nine dogs received an intravesical dose of ALA either with no prior treatment, after receiving ammonium chloride for urinary acidification, or after receiving sodium bicarbonate for urinary alkalinization. Urine and blood samples collected during and after administration were monitored for ALA using an HPLC assay developed in our laboratories. Concentrations of pyrazine 2,5-dipropionic acid, the major ALA degradation product, and radiolabeled inulin, a nonabsorbable marker for urine volume, were also determined.

Results. Less than 0.6% of intravesical ALA doses was absorbed into plasma. Urine concentrations decreased to 37% of the initial concentration during the 2 hour instillation. Decreases in urinary ALA and radiolabeled inulin concentrations were significantly correlated, indicating that urine dilution accounted for over 80% of observed decreases in urinary ALA. ALA conversion to pyrazine 2,5-dipropionic acid was negligible.

Conclusions. These studies demonstrate that ALA is stable and poorly absorbed into the systemic circulation during intravesical instillation. Future studies utilizing intravesical ALA for photodiagnosis of bladder cancer should include measures to restrict fluid intake as a means to limit dilution and maximize ALA concentrations during instillation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. C. S. Loh, J. Bedwell, A. J. MacRobert, N. Krasner, D. Phillips, and S. G. Bown. Photodynamic therapy of the normal rat stomach: a comparative study between di-sulphonated aluminum phthalocyanine and 5-aminolaevulinic acid. Br. J. Cancer 66:452–462 (1992).

    Google Scholar 

  2. J. Bedwell, A. J. MacRobert, D. Phillips, and S. G. Bown. Fluorescence distribution and photodynamic effect of ALA-induced PPIX in the DMH rat colonic tumour model. Br. J. Cancer 65:818–824 (1992).

    Google Scholar 

  3. C. S. Loh, D. I. Verndon, A. J. MacRobert, J. Bedwell, S. G. Bown, and S. B. Brown. Endogenous porphyrin distribution induced by 5-aminolaevulinic acid in the tissue layers of the gastrointestinal tract. J. Photochem. Photobiol. B: Biol. 20:47–54 (1993).

    Google Scholar 

  4. S. L. Marcus, R. S. Sobel, A. L. Golub, R. L. Carroll, S. Lundahl, and D. G. Shulman. Photodynamic therapy (PDT) and photodiagnosis using endogenous photosensitization induced by 5-aminolevulinic acid (ALA): Current clinical and development status. J. Clin. Laser Med. Surg. 14:59–66 (1996).

    Google Scholar 

  5. M. Kriegmair, A. Ehsan, R. Baumgartner, W. Lumper, R. Knuechel, F. Hofstadter, P. Steinbach, and A. Hofstetter. Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid. Urology 44:836–841 (1994).

    Google Scholar 

  6. M. Kriegmair, R. Baumgartner, R. Knuchel, H. Stepp, F. Hofstadter, and A. Hofstetter. Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence. J. Urol. 155:105–110 (1996).

    Google Scholar 

  7. I. Bossenmaier and R. Cardinal. Stability of ∂-aminolevulinic acid and porphobilinogen in urine under varying conditions. Clin. Chem. 14:610–614 (1968).

    Google Scholar 

  8. W. F. Vincent and W. W. Ullman The preservation of urine specimens for ∂-aminolevulinic acid determinations. Clin. Chem. 16:612–613 (1970).

    Google Scholar 

  9. M. Novo, G. Huttmann, and H. Diddens. Chemical instability of 5-aminolevulinic acid used in the fluorescence diagnosis of bladder tumours. J. Photochem. Photobiol. B: Biol. 34:143–149 (1996).

    Google Scholar 

  10. J. T. Dalton, J. L-S. Au, M. G. Wientjes, and R. A. Badalament. Pharmacokinetics of mitomycin c in patients undergoing intravesical therapy for superficial bladder cancer. Cancer Res. 51:5144–5152 (1991).

    Google Scholar 

  11. M. G. Wientjes, J. T. Dalton, R. A. Badalament, B. M. Dasani, J. R. Drago, and J. L-S. Au. A method to study drug concentration-depth profiles in tissues:mitomycin c in dog bladder wall. Pharm. Res. 8:168–173 (1991).

    Google Scholar 

  12. J. T. Dalton, M. C. Meyer, and A. L. Golub. Pharmacokinetics of aminolevulinic acid in dogs. 1. Oral and intravenous administration. Submitted (1998).

  13. J. L-S. Au, J. T. Dalton, and M. G. Wientjes. Evidence of significant absorption of sodium salicylate from urinary bladder of rats. J. Pharmacol. Exp. Ther. 258:357–364 (1991).

    Google Scholar 

  14. W. F. Loeb and F. W. Quimby. The Clinical Chemistry of Laboratory Animals, Pergamon Press, New York, 1989.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to James T. Dalton.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dalton, J.T., Zhou, D., Mukherjee, A. et al. Pharmacokinetics of Aminolevulinic Acid After Intravesical Administration to Dogs. Pharm Res 16, 288–295 (1999). https://doi.org/10.1023/A:1018840827910

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1018840827910

Navigation